For people living with non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be removed by surgery, and whose tumor is KRAS G12C positive, and who have received at least one prior treatment.1



In a clinical trial, 126 adults were given an oral treatment called LUMAKRAS™. The trial evaluated how many adults responded to LUMAKRAS™, meaning their tumors either shrank or disappeared from initial scan. The trial also measured how long the tumor responded to LUMAKRAS™.1

Important Considerations: The approval of LUMAKRAS™ in these patients is based on a study that measured the size of tumor shrinkage. Talk to your doctor to see if LUMAKRAS™ is right for you.


Ask your doctor if LUMAKRAS may be right for you